A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.

BMC Bioinformatics · 2021 · PMC7923321 · PMID 33653269

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp < 3.2e−13actually significant

Highly significant differences were also observed with PTPN14 ( p < 3.2e−13), SDC4 ( p < 3.2e−13), CKAP4 ( p < 3e−12), ADAM9 ( p < 3.3e−11), and PIK3CG ( p < 2.3 e−10).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.